Formycon AG (ETR:FYB)
15.48
+0.20 (1.31%)
Nov 16, 2026, 12:46 PM CET
Formycon AG Employees
Formycon AG had 196 employees as of June 30, 2026. The number of employees decreased by 7 or 3.45% since the number was reported on December 31, 2025. That makes Formycon AG the 26,984th largest employer in the world and 396th in Germany.
Employees
196
Change
-7
Growth
-3.45%
Revenue / Employee
€312,459
Profits / Employee
€128,224
Market Cap
273.58M
Employees Chart
| Date | Employees | Change | Growth | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 196 | -7 | -3.45% | 196 | 0 |
| Dec 31, 2025 | 203 | -47 | -18.80% | 203 | 0 |
| Dec 31, 2024 | 250 | 12 | 5.04% | 250 | 0 |
| Dec 31, 2023 | 238 | 33 | 16.10% | 238 | 0 |
| Dec 31, 2022 | 205 | 34 | 19.88% | 205 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fresenius SE & Co. KGaA | 179,493 |
| Bayer Aktiengesellschaft | 87,775 |
| Siemens Healthineers AG | 74,600 |
| Merck KGaA | 61,949 |
| MEDICLIN Aktiengesellschaft | 7,055 |
| Evotec SE | 4,379 |
| Stratec SE | 1,383 |
| Medios AG | 989 |
Formycon AG News
- 3 days ago - Formycon AG Earnings Call Transcript: Q3 2026 - Transcripts
- 3 days ago - Formycon AG Earnings release: Q3 2026 - Filings
- 3 days ago - Formycon AG Slides: Q3 2026 - Filings
- 4 days ago - Formycon Doubles Nine-Month Revenue as FYB4Growth Gains Momentum - Wallstreet:Online
- 4 days ago - EQS-News: Formycon Doubles Nine-Month Revenue and Consistently Advances Implementation of its FYB4Growth Strategy - Wallstreet:Online
- 10 days ago - Formycon Revises EBITDA Guidance After FYB201/FYB202 Non-Cash Impairments - Wallstreet:Online
- 10 days ago - Formycon Holds 2026 Outlook, Revises Adj. EBITDA, Reassesses FYB201/202 - Wallstreet:Online
- 10 days ago - EQS-News: Formycon maintains 2026 guidance for revenue, EBITDA and working capital, revises adjusted EBITDA and reassesses FYB201 and FYB202 - Wallstreet:Online